{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T08:21:10Z","timestamp":1787732470094,"version":"build-2784847793"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2021,6,11]],"date-time":"2021-06-11T00:00:00Z","timestamp":1623369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2021,6,11]],"date-time":"2021-06-11T00:00:00Z","timestamp":1623369600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"F. Hoffmann-La Roche, Ltd."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1007\/s12325-021-01790-y","type":"journal-article","created":{"date-parts":[[2021,6,11]],"date-time":"2021-06-11T20:02:30Z","timestamp":1623441750000},"page":"4040-4056","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Disease Behaviour During the Peri-Diagnostic Period in Patients with Suspected Interstitial Lung Disease: The STARLINER Study"],"prefix":"10.1007","volume":"38","clinical-trial-number":[{"clinical-trial-number":"nct03261037","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Marlies S.","family":"Wijsenbeek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Bendstrup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Valenzuela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael T.","family":"Henry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catharina C.","family":"Moor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Jouneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro G.","family":"Fois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Onofre","family":"Moran-Mendoza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed","family":"Anees","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirela","family":"Mirt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Bengus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Gilberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus-Uwe","family":"Kirchgaessler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Vancheri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,11]]},"reference":[{"key":"1790_CR1","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1097\/MCP.0b013e328363f48d","volume":"19","author":"CJ Ryerson","year":"2013","unstructured":"Ryerson CJ, Collard HR. Update on the diagnosis and classification of ILD. Curr Opin Pulm Med. 2013;19:453\u20139.","journal-title":"Curr Opin Pulm Med"},{"key":"1790_CR2","first-page":"256","volume-title":"European Lung White Book","author":"GJ Gibson","year":"2013","unstructured":"Gibson GJ. Interstitial lung diseases. In: Gibson GJ, Loddenkemper R, Sibille Y, Lundb\u00e4ck B, Fletcher M, editors. European Lung White Book. 2nd ed. Sheffield: European Respiratory Society; 2013. p. 256\u201369.","edition":"2"},{"key":"1790_CR3","doi-asserted-by":"publisher","first-page":"180076","DOI":"10.1183\/16000617.0076-2018","volume":"27","author":"V Cottin","year":"2018","unstructured":"Cottin V, Hirani NA, Hotchkin DL, et al. Presentation, diagnosis and clinical course of the spectrum of progressive-fibrosing interstitial lung diseases. Eur Respir Rev. 2018;27:180076.","journal-title":"Eur Respir Rev"},{"key":"1790_CR4","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1056\/NEJMoa1402584","volume":"370","author":"L Richeldi","year":"2014","unstructured":"Richeldi L, du Bois RM, Raghu G, et al. Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. N Engl J Med. 2014;370:2071\u201382.","journal-title":"N Engl J Med"},{"key":"1790_CR5","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1016\/S0140-6736(11)60405-4","volume":"377","author":"PW Noble","year":"2011","unstructured":"Noble PW, Albera C, Bradford WZ, et al. Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials. Lancet. 2011;377:1760\u20139.","journal-title":"Lancet"},{"key":"1790_CR6","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1056\/NEJMoa1402582","volume":"370","author":"TE King Jr","year":"2014","unstructured":"King TE Jr, Bradford WZ, Castro-Bernardini S, et al. A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. N Engl J Med. 2014;370:2083\u201392.","journal-title":"N Engl J Med"},{"key":"1790_CR7","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1378\/chest.12-2685","volume":"144","author":"ER Fernandez Perez","year":"2013","unstructured":"Fernandez Perez ER, Swigris JJ, Forssen AV, et al. Identifying an inciting antigen is associated with improved survival in patients with chronic hypersensitivity pneumonitis. Chest. 2013;144:1644\u201351.","journal-title":"Chest"},{"key":"1790_CR8","doi-asserted-by":"publisher","first-page":"2518","DOI":"10.1056\/NEJMoa1903076","volume":"380","author":"O Distler","year":"2019","unstructured":"Distler O, Highland KB, Gahlemann M, et al. Nintedanib for systemic sclerosis-associated interstitial lung disease. N Engl J Med. 2019;380:2518\u201328.","journal-title":"N Engl J Med"},{"key":"1790_CR9","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1007\/s12325-019-00992-9","volume":"36","author":"TM Maher","year":"2019","unstructured":"Maher TM, Wuyts W. Management of fibrosing interstitial lung diseases. Adv Ther. 2019;36:1518\u201331.","journal-title":"Adv Ther"},{"key":"1790_CR10","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12890-016-0171-y","volume":"16","author":"AM Russell","year":"2016","unstructured":"Russell AM, Ripamonti E, Vancheri C. Qualitative European survey of patients with idiopathic pulmonary fibrosis: patients\u2019 perspectives of the disease and treatment. BMC Pulm Med. 2016;16:10.","journal-title":"BMC Pulm Med"},{"key":"1790_CR11","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12890-017-0560-x","volume":"18","author":"GP Cosgrove","year":"2018","unstructured":"Cosgrove GP, Bianchi P, Danese S, Lederer DJ. Barriers to timely diagnosis of interstitial lung disease in the real world: the INTENSITY survey. BMC Pulm Med. 2018;18:9.","journal-title":"BMC Pulm Med"},{"key":"1790_CR12","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1164\/rccm.201104-0668OC","volume":"184","author":"DJ Lamas","year":"2011","unstructured":"Lamas DJ, Kawut SM, Bagiella E, Philip N, Arcasoy SM, Lederer DJ. Delayed access and survival in idiopathic pulmonary fibrosis: a cohort study. Am J Respir Crit Care Med. 2011;184:842\u20137.","journal-title":"Am J Respir Crit Care Med"},{"key":"1790_CR13","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1183\/09059180.00001213","volume":"22","author":"AU Wells","year":"2013","unstructured":"Wells AU. Managing diagnostic procedures in idiopathic pulmonary fibrosis. Eur Respir Rev. 2013;22:158\u201362.","journal-title":"Eur Respir Rev"},{"key":"1790_CR14","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1183\/13993003.01204-2015","volume":"47","author":"F Bonella","year":"2016","unstructured":"Bonella F, Wijsenbeek M, Molina-Molina M, et al. European IPF Patient Charter: unmet needs and a call to action for healthcare policymakers. Eur Respir J. 2016;47:597\u2013606.","journal-title":"Eur Respir J"},{"key":"1790_CR15","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s12931-019-1076-0","volume":"20","author":"N Hoyer","year":"2019","unstructured":"Hoyer N, Prior TS, Bendstrup E, Wilcke T, Shaker SB. Risk factors for diagnostic delay in idiopathic pulmonary fibrosis. Respir Res. 2019;20:103.","journal-title":"Respir Res"},{"key":"1790_CR16","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/S2213-2600(17)30433-2","volume":"6","author":"DA Lynch","year":"2018","unstructured":"Lynch DA, Sverzellati N, Travis WD, et al. Diagnostic criteria for idiopathic pulmonary fibrosis: a Fleischner Society White Paper. Lancet Respir Med. 2018;6:138\u201353.","journal-title":"Lancet Respir Med"},{"key":"1790_CR17","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1007\/s12325-018-0845-3","volume":"36","author":"M Wijsenbeek","year":"2019","unstructured":"Wijsenbeek M, Bendstrup E, Valenzuela C, et al. Design of a study assessing disease behaviour during the peri-diagnostic period in patients with interstitial lung disease: the STARLINER Study. Adv Ther. 2019;36:232\u201343.","journal-title":"Adv Ther"},{"key":"1790_CR18","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/S2213-2600(19)30341-8","volume":"8","author":"TM Maher","year":"2020","unstructured":"Maher TM, Corte TJ, Fischer A, et al. Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: a double-blind, randomised, placebo-controlled, phase 2 trial. Lancet Respir Med. 2020;8:147\u201357.","journal-title":"Lancet Respir Med"},{"key":"1790_CR19","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1513\/AnnalsATS.201605-418OC","volume":"13","author":"MJ Hegewald","year":"2016","unstructured":"Hegewald MJ, Gallo HM, Wilson EL. Accuracy and quality of spirometry in primary care offices. Ann Am Thorac Soc. 2016;13:2119\u201324.","journal-title":"Ann Am Thorac Soc"},{"key":"1790_CR20","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1111\/j.1440-1843.2006.00842.x","volume":"11","author":"JA Walters","year":"2006","unstructured":"Walters JA, Wood-Baker R, Walls J, Johns DP. Stability of the EasyOne ultrasonic spirometer for use in general practice. Respirology. 2006;11:306\u201310.","journal-title":"Respirology"},{"key":"1790_CR21","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1016\/S2213-2600(20)30452-5","volume":"8","author":"G Nakshbandi","year":"2020","unstructured":"Nakshbandi G, Moor CC, Wijsenbeek MS. Home monitoring for patients with ILD and the COVID-19 pandemic. Lancet Respir Med. 2020;8:1172\u20134.","journal-title":"Lancet Respir Med"},{"key":"1790_CR22","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1164\/rccm.202002-0328OC","volume":"202","author":"C Moor","year":"2020","unstructured":"Moor C, Mostard RLM, Grutters JC, et al. Home monitoring in patients with idiopathic pulmonary fibrosis: a randomized controlled trial. Am J Respir Crit Care Med. 2020;202:393\u2013401.","journal-title":"Am J Respir Crit Care Med"},{"key":"1790_CR23","doi-asserted-by":"publisher","first-page":"1702508","DOI":"10.1183\/13993003.02508-2017","volume":"51","author":"CC Moor","year":"2018","unstructured":"Moor CC, van Manen MJG, Tak NC, van Noort E, Wijsenbeek MS. Development and feasibility of an eHealth tool for idiopathic pulmonary fibrosis. Eur Respir J. 2018;51:1702508.","journal-title":"Eur Respir J"},{"key":"1790_CR24","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s12931-018-0810-3","volume":"19","author":"CC Moor","year":"2018","unstructured":"Moor CC, Wapenaar M, Miedema JR, Geelhoed JJM, Chandoesing PP, Wijsenbeek MS. A home monitoring program including real-time wireless home spirometry in idiopathic pulmonary fibrosis: a pilot study on experiences and barriers. Respir Res. 2018;19:105.","journal-title":"Respir Res"},{"issue":"Suppl 63","key":"1790_CR25","first-page":"PA1333","volume":"54","author":"S Swigris","year":"2019","unstructured":"Swigris S, Nathan S, Tighe R, et al. STARMAP: an observational study to assess disease-relevant outcomes using home-monitoring devices in patients with idiopathic pulmonary fibrosis (IPF). Eur Respir J. 2019;54(Suppl 63):PA1333.","journal-title":"Eur Respir J"},{"key":"1790_CR26","doi-asserted-by":"publisher","first-page":"1602406","DOI":"10.1183\/13993003.02406-2016","volume":"50","author":"KA Johannson","year":"2017","unstructured":"Johannson KA, Vittinghoff E, Morisset J, Lee JS, Balmes JR, Collard HR. Home monitoring improves endpoint efficiency in idiopathic pulmonary fibrosis. Eur Respir J. 2017;50:1602406.","journal-title":"Eur Respir J"},{"key":"1790_CR27","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1016\/j.chest.2020.04.019","volume":"158","author":"AW Wong","year":"2020","unstructured":"Wong AW, Fidler L, Marcoux V, et al. Practical considerations for the diagnosis and treatment of fibrotic interstitial lung disease during the coronavirus disease 2019 pandemic. Chest. 2020;158:1069\u201378.","journal-title":"Chest"},{"key":"1790_CR28","doi-asserted-by":"publisher","first-page":"e000439","DOI":"10.1136\/bmjresp-2019-000439","volume":"6","author":"F Khan","year":"2019","unstructured":"Khan F, Stewart I, Howard L, et al. The Its Not JUST Idiopathic pulmonary fibrosis Study (INJUSTIS): description of the protocol for a multicentre prospective observational cohort study identifying biomarkers of progressive fibrotic lung disease. BMJ Open Respir Res. 2019;6:e000439.","journal-title":"BMJ Open Respir Res"},{"key":"1790_CR29","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1136\/thoraxjnl-2020-214944","volume":"76","author":"APY Tsai","year":"2020","unstructured":"Tsai APY, Hur SA, Wong A, et al. Minimum important difference of the EQ-5D-5L and EQ-VAS in fibrotic interstitial lung disease. Thorax. 2020;76:37\u201343.","journal-title":"Thorax"},{"key":"1790_CR30","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s12931-020-01359-3","volume":"21","author":"TS Prior","year":"2020","unstructured":"Prior TS, Hoyer N, Hilberg O, Shaker SB, Davidsen JR, Bendstrup E. Responsiveness and minimal clinically important difference of SGRQ-I and K-BILD in idiopathic pulmonary fibrosis. Respir Res. 2020;21:91.","journal-title":"Respir Res"},{"key":"1790_CR31","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1164\/rccm.201308-1483ST","volume":"188","author":"WD Travis","year":"2013","unstructured":"Travis WD, Costabel U, Hansell DM, et al. An official American Thoracic Society\/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med. 2013;188:733\u201348.","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-021-01790-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-021-01790-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-021-01790-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T16:39:21Z","timestamp":1628613561000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-021-01790-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,11]]},"references-count":31,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["1790"],"URL":"https:\/\/doi.org\/10.1007\/s12325-021-01790-y","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,11]]},"assertion":[{"value":"9 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}